Eiger BioPharmaceuticals, Inc. Insider Trading for April 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eiger BioPharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eiger BioPharmaceuticals, Inc. for April 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Option Exercise | M | 8.00 | 6,629 | 53,032 | 645,717 | |
| Apr 07 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Option Exercise | M | 1.12 | 41,302 | 46,258 | 652,346 | |
| Apr 07 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Sell | S | 18.44 | 6,629 | 122,239 | 3,125 | 9.8 K to 3.1 K (-67.96 %) |
| Apr 07 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Sell | S | 18.16 | 41,302 | 750,044 | 9,754 | 51.1 K to 9.8 K (-80.90 %) |
| Apr 07 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Buy | M | 8.00 | 6,629 | 53,032 | 51,056 | 44.4 K to 51.1 K (+14.92 %) |
| Apr 07 2015 | EIGR | Eiger BioPharmaceu ... | ZSEBO KRISZTINA M | Chief Executive Off ... | Buy | M | 1.12 | 41,302 | 46,258 | 44,427 | 3.1 K to 44.4 K (+1,321.66 %) |
| Apr 03 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Option Exercise | M | 8.00 | 1,012 | 8,096 | 150,726 | |
| Apr 03 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Option Exercise | M | 1.12 | 10,000 | 11,200 | 151,738 | |
| Apr 03 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Sell | S | 16.95 | 1,012 | 17,153 | 2,895 | 3.9 K to 2.9 K (-25.90 %) |
| Apr 03 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Sell | S | 17.33 | 10,000 | 173,300 | 3,907 | 13.9 K to 3.9 K (-71.91 %) |
| Apr 03 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Buy | M | 8.00 | 1,012 | 8,096 | 13,907 | 12.9 K to 13.9 K (+7.85 %) |
| Apr 03 2015 | EIGR | Eiger BioPharmaceu ... | LABA REBECQUE J | VP, Corporate Opera ... | Buy | M | 1.12 | 10,000 | 11,200 | 12,895 | 2.9 K to 12.9 K (+345.42 %) |
| Apr 03 2015 | EIGR | Eiger BioPharmaceu ... | TAKEYA RYAN K | VP, Manufacturing | Option Exercise | M | 1.12 | 4,444 | 4,977 | 139,574 | |
| Apr 03 2015 | EIGR | Eiger BioPharmaceu ... | TAKEYA RYAN K | VP, Manufacturing | Sell | S | 19.13 | 4,444 | 85,014 | 1,432 | 5.9 K to 1.4 K (-75.63 %) |
| Apr 03 2015 | EIGR | Eiger BioPharmaceu ... | TAKEYA RYAN K | VP, Manufacturing | Buy | M | 1.12 | 4,444 | 4,977 | 5,876 | 1.4 K to 5.9 K (+310.34 %) |